a:head bio AG

A:head bio ag email format

Verified email-pattern data for A:head Bio Ag is currently limited. You can still use the company insights and contact sections below.
a:head’s drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini brains from human stem cells in vitro. They capture the essential aspects of human embryonic brain development including brain patterning, formation of brain ventricles, differentiation into the various neuronal and supportive cell types and their correct three-dimensional arrangement. The technology has been pioneered by the company’s co-founders Madeline Lancaster and Juergen Knoblich and is exclusively licensed to a:head by the Institute of Molecular Biotechnology, Vienna, Austria. a:head applies these complex 3D tissue cultures for modelling of various brain disorders in a human context and aims at translating the technology into a powerful high content, high throughput phenotyping platform for the development of novel CNS therapeutics.

Company Details

Employees
20
Address
Dr.-Bohr-Gasse 7, Vienna,wien 1030,austria
Industry
Pharmaceutical Manufacturing
Keywords
into unified.
HQ
Vienna, Wien
Looking for a particular a:head bio AG employee's phone or email?

A:head Bio Ag Questions

Explore related pages

Related company profiles:

Top a:head bio AG Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant